Skip to content

Optimization of Mechanical Ventilation Weaning Strategies in AECOPD Based on Multimodal Respiratory Support Combined with Dynamic Assessment

Optimization of Mechanical Ventilation Weaning Strategies in AECOPD Based on Multimodal Respiratory Support Combined with Dynamic Assessment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600118807
Enrollment
Unknown
Registered
2026-02-11
Start date
2026-02-20
Completion date
Unknown
Last updated
2026-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic obstructive pulmonary disease (COPD)

Interventions

Control Group:Conventional Pressure Support Ventilation Breathing Exercise
Experimental Group:Early implementation of low-level Pressure Support Ventilation combined with endotracheal high-flow oxygen therapy and training during mechanical vent

Sponsors

Hangzhou Linping Hospital of Integrated Traditional Chinese and Western Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Diagnosed with AECOPD (meeting GOLD criteria) complicated by respiratory failure requiring endotracheal intubation. 2.Age >=18 years. 3.Eligible for early respiratory rehabilitation (e.g., hemodynamically stable, FiO2 <=60%, PEEP =8 cmH2O). 4.Awake after discontinuation of sedatives and analgesics. 5.Informed consent obtained and signed by the patient's family or legal representative.

Exclusion criteria

Exclusion criteria: 1.Family refusal to participate in the clinical trial. 2.Comorbidities that significantly interfere with weaning training, including but not limited to: Intracerebral hemorrhage or massive cerebral infarction with impaired consciousness; Decompensated heart failure, severe cardiogenic shock affecting hemodynamics; Decompensated liver failure (Child-Pugh Class C) with hepatic coma; Renal failure with anuria requiring immediate bedside blood purification therapy. 3.Neurological diseases resulting in restricted or complete loss of spontaneous respiratory function. 4.Prior tracheostomy with long-term ventilator dependence. 5.Severe immunocompromised patients. 6.Terminal status (e.g., advanced cancer) with an expected survival time <72 hours, or family decision to withhold aggressive treatment. 7. Pregnant women.

Design outcomes

Primary

MeasureTime frame
Reintubation within 28 days post-extubation due to aspiration or impaired respiratory drive.;

Secondary

MeasureTime frame
Spontaneous Breathing Trial (SBT);Weaning Parameters Related to Respiratory Mechanics;

Countries

China

Contacts

Public ContactWang XiaoLiang

Hangzhou Linping Hospital of Integrated Traditional Chinese and Western Medicine

1106647715@qq.com+86 571 8623 4809

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026